EGFR and non-small cell lung carcinoma: Provided the model that WB-308 inhibits EGFR signaling pathway to different degrees in the EGFR-WT cell and EGFR-L858R cell, we examined whether WB-308 suppressed NSCLC cell proliferation to different degrees using the SRB assay, too.